DISTRIBUTION AGREEMENT
This Distribution Agreement (the "Agreement") is effective per 1 December
2013
BETWEEN: EMERALD MEDICAL APPLICATIONS LTD. (the "Company"), a corporation
organized and existing under the laws of the State of Israel with its head
office located at:
0,Xxxxxx Xxxxxx, Xxxxxx, 0000000, XXXXXX
AND: X.Xxxxxxxx - Creatiekracht (the "Distributor"), a corporation organized and
existing under the laws of the Netherlands, with its head office located at:
Xxxxxx 00, 0000XX Xxxxx, Xxxxxxxxxxx
RECITALS
WHEREAS, Company has developed DermaCompare, Software as a Service (SaaS)
platform described in Schedule A attached here (the "Products") and desires to
grant Distributor
the right to market and distribute the Products; and
WHEREAS, Distributor is in the business of marketing and distributing medical
products and desires to have Developer grant to it the right to market and
distribute the Products.
NOW, THEREFORE, in consideration of the mutual promises set forth herein, the
parties hereto agree as follows:
1. DEFINITIONS
When used in this Agreement, the following terms shall have the respective
meanings indicated, such meanings to be applicable to both the singular and
plural forms of the terms defined:
"Agreement" means this agreement, the Schedules attached hereto and any
documents included by reference, as each may be amended from time to time in
accordance with the terms of this Agreement.
"Customer" or "End-User" means any person or company who purchases products from
Distributor.
"Delivery Point" means software server at Company's facilities
"Territory" means the geographic area or areas identified in paragraphs 2 & 3.
"Trademark" means any trademark, logo, service xxxx or other commercial
designation, whether or not registered, used to represent or describe the
Products of the Company and the Company itself.
2. APPOINTMENT OF DISTRIBUTOR
The Company hereby appoints the Distributor as a Company's exclusive distributor
of her Products regarding Dermatology in the Territory - The Netherlands, and
Distributor accepts that position.
3. DILIGENCE
3.1. The Distributor agrees to act diligently, conscientiously and faithfully to
distribute the DermaCompare platform under this Agreement, and will provide the
best promotional marketing services.
3.2. The distributor will work in the target geographies - The Netherlands, in
accordance with its laws. The Company will not have any legal liability for any
activity or violation of these laws by Distributor. It is further emphasized
that if the Company will be sued by any person or organization - private or
government regarding activities of the Distributor, the distributor shall bear
all legal and financial responsibility for any act against the company.
4. NON-COMPETE
Distributor agrees that it will not distribute or represent any Products in the
Territory which compete with the Products during the term of this Agreement or
any extensions thereof.
5. SUPPORTING DOCUMENTATION & TRAINING MATERIALS
Company will provide, at its own expense, distributor catalogs, educational
materials, technical support documentation and training of DermaCompare, as
required and as it sees fit. Marketing materials will be distributed at
Distributor's expense to the target territory.
6. PRICING AND SALES COMMISSION
6.1. End-user (physician/clinic/ hospital/ photographer) will be charged $95 per
patient (U.S. Ninety Five dollars), to be paid directly to the Company, as an
annual subscription fee - providing access to DermaCompare - an image-processing
platform for comparison of photographic data, recorded over a period of one year
(unlimited number of photos can be uploaded for each patient, annually).
6.2. During the first year, Distributor will receive the right to introduce up
to 100 potential customers to use of DermaCompare at no cost (for the annual
subscription fees) - for the purpose of promotion and marketing of the system.
6.3. The Company shall pay the Distributor as follows:
6.3.1. For the first 1000 paying patients image records, during the first year -
$15 (Fifteen U.S. dollars) for the annual subscription, enabling full access to
DermaCompare patient data.
6.3.2. For the first 1000 paying patients image records, during the following
years - $10 (Ten U.S. dollars) for the annual subscription, enabling full access
to DermaCompare patient data.
6.3.3. For the following 1001-5000 patient image records - $15 (Fifteen U.S.
Dollars) for the annual subscription, enabling full access to DermaCompare
patient data.
6.3.4. For 5001 patient image records and above (during that year) - $20 (Twenty
U.S. Dollars) for the annual subscription, enabling full access to DermaCompare
patient data.
6.4. Special success fees for 20,000 or more patients image records per year -
Success fee will be based on an additional 3% of the annual turnover.
6.5. Section 6 price quotes are "gross" and include tax.
6.6. After termination of the Agreement the Distributor will be entitled to
Goodwill fee for 3 years. Over the first year after termination 10% of the sales
in the Neherlands, over the second year 7% and over the third year 5%
7. PAYMENT
The company shall pay the Distributor fee monthly over the received invoices
from end users in the month before this date. Company gives Distributor real
time insight in paymants by End-users in the Netherlands.
8. DELIVERY
8.1. The Company will provide analysis (comparison between the images in each
set) within 72 hours (3 working days) after receipt of the images in the
DermaCompare database. Otherwise Distributor has the right to cancel the
subscription - either for the specific patient or specific set of images, and
without receiving payment for this subscription. Distributor will not be
entitled to receive additional free subscriptions in lieu (?) of cancellation of
a free subscription.
8.2. Company shall not be responsible for a delay in any order in the following
cases:
8.2.1. Force Majeure and without prejudice to the generality of the above - war,
hostilities, emergency situations and natural disasters. Neither party shall be
liable or deemed to be in default for any delay or failure in performance under
this Agreement or interruption of service resulting directly or indirectly from
acts of God, or any causes beyond the reasonable control of such party.
8.2.2. Damage to materials used within the system.
8.3. If a situation described in Section 8.2 applies, section 7 above will be
affected.
9. ASSIGNMENT
This Agreement is not assignable by either party hereto, without a written
consent from the other party, This Agreement shall be binding upon and inure to
the benefit of the parties and their respective successors.
Distributor shall give all information required for the assignment of rights
with full disclosure to the Company at least 30 days prior to assignment of
rights coming into effect.
10. AGREEMENT TERM
10.1. This Agreement shall have an initial term of THREE years from the
Effective Date (the "Initial Term"), and shall thereafter automatically renew
for successive 3 additional periods of one year each (each a "Renewal Term"),
unless earlier terminated in accordance with the terms of this Agreement. Either
party may cancel this Agreement effective 30 days prior to end of Agreement and
/ or extension of the agreement, by serving written notice of such termination
on the other party.
10.2. The Company and the Distributor are hereby given an option to extend the
agreement to 3 additional periods of one year each, and provided that mutual
notification in writing to each other shall be conducted at least 30 days before
the end of the agreement and / or extension of the agreement as expressed by
both sides.
10.3. Distributor shall have the right to cancel the agreement at any time,
provided that the Company is informed at least 30 days in advance - and in
writing. In this case, Distributor shall be prohibited to conduct any activity
in this area (marketing) for a period of three years.
10.4. The Company shall be entitled to cancel the agreement at any of the
following conditions:
10.4.1. If Distributor has not introduced more than 500 patient image records
during a period of one year after Dermacompare is fully operational in the
Netherlands- full payment.
10.4.2. If Distributor has not sold at least 3,000 patient image records by the
second consecutive year - full payment.
10.4.3. If Distributor has not sold at least 10,000 image records in the third
year - full payment.
10.4.4. Distributor violates basic clause in this Agreement and has failed to
correct the violation within 30 days from the period required to do so in
writing.
10.4.5. Distributor has been declared insolvent or bankrupt.
11. TRANSFER OF OWNERSHIP
If parties sell ownership of the product / services to new owners, the rights
and obligations of this Agreement shall be fully re-assigned to the new owner.
12. FUNDAMENTAL BREACH OF AGREEMENT
It is hereby agreed that the provisions of sections 2, 3, 4, 6 to this Agreement
shall be deemed Sections elementary principal , and breach of all or any of them
shall be deemed a fundamental breach of this Agreement within the meaning of
this term - under the Contracts (Remedies for Breach of Contract) , which
related to - in 1970 .
The Parties agree that any dispute between the parties will be heard in the
Magistrate's Court in Tel Aviv - Jaffa.
13. STAMP DUTY
Stamp Duty applicable to this Agreement shall apply to the parties equally.
14. NOTICES
Any notice sent by registered mail by one party to another at the address
indicated in the introduction to the agreement shall be deemed reaching its
destination 72 hours after being sent via registered mail or hand-delivered by
hand - at the time of delivery .
IN WITNESS WHEREOF, the parties have executed this Agreement on the dates set
forth first above, with full knowledge of its content and significance and
intending to be legally bound by the terms hereof.
COMPANY DISTRIBUTOR
Authorized Signature Authorized Signature
Print Name and Title Print Name and Title
